A randomized, controlled trial comparing the immunogenicity of 2 doses vs 3 doses of the 9-valent HPV vaccine in males and females 15- 26 years of age

    Project: Other project

    StatusActive
    Effective start/end date3/1/192/28/22

    Funding

    • Cancer Prevention and Research Institute: $474,164.00